As these tumour-suppressive effects in the Acly KO occurred independently of changes in liver histology, and the TTR-Cre promoter used to induce deletion does not affect immune cells26, these studies provide surprising findings about how inhibiting ACLY not only suppresses tumour proliferation but also enhances immunogenicity. The gene discussed is TTR; the disease is neoplasm.